PAR 7.50% 21.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 601 Posts.
    lightbulb Created with Sketch. 140
    I noted that also - no mention of any "Business Development". Whereas in the last quarterly they said, "Discussions are ongoing with a number of potential partners".

    So, either things have dried up abd we have nothing going on until P3 gets approved, or they have something lined up and will meet June 30 deadline, even if a $10mn upfront MPS deal. I'm thinking it is the former but one can only live in hope.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.